Results 21 to 30 of about 44,284 (201)

Molecular Determinants of Mouse Adaptation of Rat Hepacivirus

open access: yesJournal of Virology, 2023
A prophylactic vaccine is required to achieve the World Health Organization’s objective for hepatitis C virus elimination as a serious public health threat. However, the lack of robust immunocompetent animal models supporting hepatitis C virus infection impedes vaccine development as well as studies of immune responses and viral evasion.
Wolfisberg, Raphael   +11 more
openaire   +3 more sources

Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response

open access: yesMicrobiology Spectrum, 2022
More than 70 million people worldwide are still infected with the hepatitis C virus 30 years after its discovery, underscoring the need for a vaccine. To develop an effective prophylactic vaccine, detailed knowledge of the correlates of protection and an
André Gömer   +9 more
doaj   +1 more source

Discovery of Jogalong virus, a novel hepacivirus identified in a Culex annulirostris (Skuse) mosquito from the Kimberley region of Western Australia.

open access: yesPLoS ONE, 2020
The discovery of hepaciviruses in non-human hosts has accelerated following the advancement of high-throughput sequencing technology. Hepaciviruses have now been described in reptiles, fish, birds, and an extensive array of mammals.
Simon H Williams   +11 more
doaj   +1 more source

Prevalence of equine hepacivirus infection in Mongolia

open access: yesVirus Research, 2020
Equine hepacivirus (EHV) belongs to the hepacivirus A and is related to hepatitis C virus (HCV). This virus shows hepatic tropism and is known to chronically infect horses. EHV has been reported from various countries, but the prevalence in Mongolia, where large horse populations are pastured, remains unknown.
Tomoko, Date   +5 more
openaire   +2 more sources

Histopathology of chronic hepatitis C in relation to virus genotype [PDF]

open access: yesVojnosanitetski Pregled, 2006
Background/aim: The natural history of hepatitis C virus (HCV) infection is variable and the factors determining the course of the illness are unclear. There are geographical variations in the distribution of different HCV genotypes, and some of them are
Simonović Jasmina   +8 more
doaj   +1 more source

Hepatitis C virus (Flaviviridae: Hepacivirus: Hepacivirus C): regulation of signaling reactions of innate immunity

open access: yesProblems of Virology, 2021
Studying the regulation of signaling reactions of innate immunity by the hepatitis C virus (HCV) will help to reveal the causes of the transition of the acute form of the disease to a chronic course. The molecular mechanisms of activation by HCV RNA of innate immunity receptors TLR and RLR and signal transduction processes leading to the synthesis of ...
openaire   +4 more sources

The landscape of viral associations in human cancers [PDF]

open access: yes, 2020
Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, for which whole-genome and—for a subset—whole-transcriptome sequencing data from 2,658 cancers across 38 tumor types was aggregated, we systematically investigated potential ...
Alawi, Malik   +14 more
core   +3 more sources

Non-primate hepacivirus infection with apparent hepatitis in a horse — Short communication [PDF]

open access: yes, 2014
Non-primate hepacivirus (NPHV) is a recently identified hepacivirus (family Flaviviridae) in dog and horse; however, the disease associations remain unknown.
Boros, Ákos   +3 more
core   +1 more source

Mouse models of acute and chronic hepacivirus infection [PDF]

open access: yesScience, 2017
New York City rats provide a gift to virologists Despite the development of curative drugs for hepatitis C virus (HCV) infection, global eradication of HCV will likely require a prophylactic vaccine. Progress toward a vaccine has been impeded by the absence of mouse models suitable for studying the immune response
Eva Billerbeck   +14 more
openaire   +3 more sources

Blocking Zika virus vertical transmission. [PDF]

open access: yes, 2018
The outbreak of the Zika virus (ZIKV) has been associated with increased incidence of congenital malformations. Although recent efforts have focused on vaccine development, treatments for infected individuals are needed urgently. Sofosbuvir (SOF), an FDA-
Beltrão-Braga, Patricia CB   +23 more
core   +2 more sources

Home - About - Disclaimer - Privacy